Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis.

Matteo Ruggeri

doi:10.5301/GRHTA.5000232

Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis.

Matteo Ruggeri

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Abstract

[Ita:]Valutazione economica HTA

Titolo tradotto del contributo	[Autom. eng. transl.] Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis.
Lingua originale	Italian
pagine (da-a)	125-133
Numero di pagine	9
Rivista	Quality and Quantity
DOI	https://doi.org/10.5301/GRHTA.5000232
Stato di pubblicazione	Pubblicato - 2016

Keywords

Valutazione economica

Accesso al documento

10.5301/GRHTA.5000232

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{b950d8f781cb4fe5acf8294114afeeb0,

title = "Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis.",

abstract = "[Ita:]Valutazione economica HTA",

keywords = "Valutazione economica, Valutazione economica",

author = "Matteo Ruggeri",

year = "2016",

doi = "10.5301/GRHTA.5000232",

language = "Italian",

pages = "125--133",

journal = "Quality and Quantity",

issn = "1573-7845",

publisher = "Dordrecht : Kluwer",

}

TY - JOUR

T1 - Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis.

AU - Ruggeri, Matteo

PY - 2016

Y1 - 2016

N2 - [Ita:]Valutazione economica HTA

AB - [Ita:]Valutazione economica HTA

KW - Valutazione economica

UR - http://hdl.handle.net/10807/96280

U2 - 10.5301/GRHTA.5000232

DO - 10.5301/GRHTA.5000232

M3 - Articolo in rivista

SN - 1573-7845

SP - 125

EP - 133

JO - Quality and Quantity

JF - Quality and Quantity

ER -

Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis.

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo